ANDA 88157, held by Hikma. Chlorpromazine Hydrochloride.
As of Nov 16, 2026, ANDA 88157 (Chlorpromazine Hydrochloride Intensol), held by Hikma, was first approved by FDA on Apr 27, 1983, with 8 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Apr 27, 1983 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Chlorpromazine Hydrochloride Intensol30MG/ML ยท concentrate;oral | Chlorpromazine Hydrochloride | Discontinued |
| Nov 28, 2001 | Supplement 9Labeling | Approved | None posted |
| Aug 24, 1999 | Supplement 8Labeling | Approved | None posted |
| Aug 28, 1996 | Supplement 7Manufacturing | Approved | None posted |
| Apr 6, 1995 | Supplement 6Manufacturing | Approved | None posted |
| Nov 3, 1992 | Supplement 5Labeling | Approved | None posted |
| Sep 23, 1988 | Supplement 1Bioequivalence | Approved | None posted |
| Sep 13, 1988 | Supplement 3Manufacturing | Approved | None posted |
| Sep 13, 1988 | Supplement 4Manufacturing | Approved | None posted |
| Apr 27, 1983 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters